U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. Inspections, Compliance, Enforcement, and Criminal Investigations
  3. Compliance Actions and Activities
  4. Warning Letters
  5. Anna Health, LLC - 613294 - 04/04/2022
  1. Warning Letters

CLOSEOUT LETTER

Anna Health, LLC MARCS-CMS 613294 —

Delivery Method:
Electronic Email
Reference #:
22-HAFE4-WLCOL-07
Product:
Dietary Supplements
Recipient:
Recipient Name
Mr. Tin Huynh
Recipient Title
Owner
Anna Health, LLC

9724 N Armenia Avenue
Suite 400
Tampa, FL 33612-7550
United States

Issuing Office:
Division of Human and Animal Food Operations East IV

United States

Dear Mr. Huynh:

The Food and Drug Administration has completed an evaluation of your firm’s corrective actions in response to Warning Letter 21-HAFE4-WL-03 dated March 16, 2021. It appears that you have addressed the violations contained in this Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections.

This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.

Kind regards,
/S/
Pearl Lopina
Director of Compliance Branch
OHAFO East Division IV

Back to Top